227 related articles for article (PubMed ID: 24788910)
1. Acute kidney injury during concomitant use of valacyclovir and loxoprofen: detecting drug-drug interactions in a spontaneous reporting system.
Yue Z; Shi J; Jiang P; Sun H
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1154-9. PubMed ID: 24788910
[TBL] [Abstract][Full Text] [Related]
2. Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System.
Yue Z; Shi J; Li H; Li H
Biol Pharm Bull; 2018 Feb; 41(2):158-162. PubMed ID: 29187701
[TBL] [Abstract][Full Text] [Related]
3. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Ren Fail; 2014 Aug; 36(7):1166-8. PubMed ID: 24826803
[TBL] [Abstract][Full Text] [Related]
4. [Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case].
Sagawa N; Tsurutani Y; Nomura K; Okuyama T; Kondo M; Sata A; Miyao M; Mizuno Y
Nihon Ronen Igakkai Zasshi; 2014; 51(6):581-5. PubMed ID: 25749332
[TBL] [Abstract][Full Text] [Related]
5. Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.
Pipili C; Pantelias K; Deda E; Tsiamalos P; Kostis E; Grapsa E
Ren Fail; 2013; 35(2):289-90. PubMed ID: 23176110
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
7. Association of non-steroidal anti-inflammatory drug use with encephalopathy development: An analysis using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases.
Kawada K; Ishida T; Yoshioka T; Fukuda H; Hayashi T; Goda M; Ishizawa K
Pharmazie; 2024 Jun; 79(6):118-123. PubMed ID: 38877682
[TBL] [Abstract][Full Text] [Related]
8. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
9. Risk of acute kidney injury from oral acyclovir: a population-based study.
Lam NN; Weir MA; Yao Z; Blake PG; Beyea MM; Gomes T; Gandhi S; Mamdani M; Wald R; Parikh CR; Hackam DG; Garg AX
Am J Kidney Dis; 2013 May; 61(5):723-9. PubMed ID: 23312723
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
Chaudhari D; Ginn D
Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
[TBL] [Abstract][Full Text] [Related]
11. Valacyclovir neurotoxicity: clinical experience and review of the literature.
Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H
Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity caused by valacyclovir in a patient on hemodialysis.
Linssen-Schuurmans CD; van Kan EJ; Feith GW; Uges DR
Ther Drug Monit; 1998 Aug; 20(4):385-6. PubMed ID: 9712461
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure and severe neurotoxicity following valacyclovir.
Carlon R; Possamai C; Corbanese U
Intensive Care Med; 2005 Nov; 31(11):1593. PubMed ID: 16172845
[No Abstract] [Full Text] [Related]
15. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
Baker D; Eisen D
Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
[TBL] [Abstract][Full Text] [Related]
17. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir and acute renal failure.
Chavannes M; Doad RS; Doad GJS
J Med Assoc Ga; 2016; 105(3):14. PubMed ID: 29809345
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
20. Aseptic meningitis related to valacyclovir.
Fobelo MJ; Corzo Delgado JE; Romero Alonso A; Gómez-Bellver MJ
Ann Pharmacother; 2001 Jan; 35(1):128-9. PubMed ID: 11197578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
